Dian Diagnostics Group Co.,Ltd. (SHE:300244)
China · Delayed Price · Currency is CNY 16.94
+0.38 (2.29%)
Sep 5, 2025, 3:04 PM CST
Dian Diagnostics Group Revenue
Dian Diagnostics Group had revenue of 2.57B CNY in the quarter ending June 30, 2025, a decrease of -20.76%. This brings the company's revenue in the last twelve months to 10.91B, down -14.63% year-over-year. In the year 2024, Dian Diagnostics Group had annual revenue of 12.20B, down -9.04%.
Revenue (ttm)
10.91B
Revenue Growth
-14.63%
P/S Ratio
0.95
Revenue / Employee
1.24M
Employees
8,773
Market Cap
10.35B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12.20B | -1.21B | -9.04% |
| Dec 31, 2023 | 13.41B | -6.87B | -33.89% |
| Jan 1, 2023 | 20.28B | 7.20B | 55.03% |
| Jan 1, 2022 | 13.08B | 2.43B | 22.85% |
| Dec 31, 2020 | 10.65B | 2.20B | 25.98% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 30.15B |
| WuXi AppTec | 41.90B |
| Shenzhen Mindray Bio-Medical Electronics | 32.94B |
| Sichuan Biokin Pharmaceutical | 441.19M |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
| Aier Eye Hospital Group | 21.94B |
| Shanghai United Imaging Healthcare | 10.98B |
| Yunnan Baiyao Group Co.,Ltd | 40.84B |